Value drivers of development stage biopharma companies
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
17 January 2022
|
| In: |
The European journal of health economics
Year: 2022, Volume: 23, Issue: 8, Pages: 1287-1296 |
| ISSN: | 1618-7601 |
| DOI: | 10.1007/s10198-021-01427-5 |
| Subjects: | |
| Online Access: | Verlag, kostenfrei: https://link.springer.com/content/pdf/10.1007/s10198-021-01427-5.pdf Resolving-System, kostenfrei: https://doi.org/10.1007/s10198-021-01427-5 |
| Author Notes: | Daniel Tobias Michaeli, Hasan Basri Yagmur, Timur Achmadeev, Thomas Michaeli |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1819636267 | ||
| 003 | DE-627 | ||
| 005 | 20230710123413.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221021s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10198-021-01427-5 |2 doi | |
| 035 | |a (DE-627)1819636267 | ||
| 035 | |a (DE-599)KXP1819636267 | ||
| 035 | |a (OCoLC)1389536469 | ||
| 035 | |a (DE-He213)s10198-021-01427-5-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Michaeli, Daniel |d 1997- |e VerfasserIn |0 (DE-588)1277183244 |0 (DE-627)1830345109 |4 aut | |
| 245 | 1 | 0 | |a Value drivers of development stage biopharma companies |c Daniel Tobias Michaeli, Hasan Basri Yagmur, Timur Achmadeev, Thomas Michaeli |
| 264 | 1 | |c 17 January 2022 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 650 | 4 | |a Acquisitions |7 (dpeaa)DE-206 | |
| 650 | 4 | |a Drug development |7 (dpeaa)DE-206 | |
| 650 | 4 | |a Multi-indication |7 (dpeaa)DE-206 | |
| 650 | 4 | |a Orphan |7 (dpeaa)DE-206 | |
| 650 | 4 | |a Pharmaceutical policy |7 (dpeaa)DE-206 | |
| 650 | 4 | |a Valuation |7 (dpeaa)DE-206 | |
| 655 | 4 | |0 (DE-206)49 |a Aufsatz in Zeitschrift |5 DE-206 | |
| 700 | 1 | |a Yagmur, Hasan Basri |e VerfasserIn |4 aut | |
| 700 | 1 | |a Achmadeev, Timur |e VerfasserIn |4 aut | |
| 700 | 1 | |a Michaeli, Christoph T. |d 1992- |e VerfasserIn |0 (DE-588)1277182337 |0 (DE-627)1830343769 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The European journal of health economics |d Berlin : Springer, 2001 |g 23(2022), 8 vom: Nov., Seite 1287-1296 |h Online-Ressource |w (DE-627)320494462 |w (DE-600)2011428-X |w (DE-576)09670425X |x 1618-7601 |7 nnas |a Value drivers of development stage biopharma companies |
| 773 | 1 | 8 | |g volume:23 |g year:2022 |g number:8 |g month:11 |g pages:1287-1296 |g extent:10 |a Value drivers of development stage biopharma companies |
| 856 | 4 | 0 | |u https://link.springer.com/content/pdf/10.1007/s10198-021-01427-5.pdf |x Verlag |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10198-021-01427-5 |x Resolving-System |z kostenfrei |
| 951 | |a AR | ||
| 992 | |a 20230125 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1277182337 |a Michaeli, Christoph T. |m 1277182337:Michaeli, Christoph T. |d 60000 |d 61400 |e 60000PM1277182337 |e 61400PM1277182337 |k 0/60000/ |k 1/60000/61400/ |p 4 |y j | ||
| 998 | |g 1277183244 |a Michaeli, Daniel |m 1277183244:Michaeli, Daniel |d 60000 |e 60000PM1277183244 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1819636267 |e 4251374584 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Michaeli","given":"Daniel","display":"Michaeli, Daniel","role":"aut"},{"role":"aut","display":"Yagmur, Hasan Basri","given":"Hasan Basri","family":"Yagmur"},{"role":"aut","given":"Timur","family":"Achmadeev","display":"Achmadeev, Timur"},{"display":"Michaeli, Christoph T.","family":"Michaeli","given":"Christoph T.","role":"aut"}],"recId":"1819636267","id":{"doi":["10.1007/s10198-021-01427-5"],"eki":["1819636267"]},"title":[{"title":"Value drivers of development stage biopharma companies","title_sort":"Value drivers of development stage biopharma companies"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2001","dateIssuedDisp":"2001-","publisher":"Springer","publisherPlace":"Berlin ; Heidelberg"}],"title":[{"title":"The European journal of health economics","title_sort":"European journal of health economics"}],"pubHistory":["2.2001 -"],"note":["Gesehen am 10.11.23"],"recId":"320494462","id":{"issn":["1618-7601"],"zdb":["2011428-X"],"eki":["320494462"]},"language":["eng"],"disp":"Value drivers of development stage biopharma companiesThe European journal of health economics","physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"23(2022), 8 vom: Nov., Seite 1287-1296","year":"2022","issue":"8","extent":"10","volume":"23","pages":"1287-1296"},"titleAlt":[{"title":"Eur J Health Econ"},{"title":"HEPAC"}]}],"name":{"displayForm":["Daniel Tobias Michaeli, Hasan Basri Yagmur, Timur Achmadeev, Thomas Michaeli"]},"origin":[{"dateIssuedDisp":"17 January 2022","dateIssuedKey":"2022"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"10 S."}],"language":["eng"]} | ||
| SRT | |a MICHAELIDAVALUEDRIVE1720 | ||